Coronavirus Clinical Trials

A listing of Coronavirus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 528 clinical trials
Study of Gam-COVID-Vac in Adolescents

of coronavirus infection caused by the virus SARS-CoV-2" in adolescents

  • 0 views
  • 24 Sep, 2021
  • 2 locations
Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

The COVID-19 pandemic has been characterized by high morbidity and mortality, especially in certain subgroups of patients. To date, no treatment has been shown to be effective in patients with early-onset disease and mild symptoms. Experimental studies have demonstrated a potential anti-inflammatory role of Fluvoxamine, Fluoxetine, Budesonide and Pegilatrd Interferon …

  • 0 views
  • 04 Oct, 2022
  • 12 locations
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Concomitant Administration of Either 23-Valent Pneumococcal Polysaccharide Vaccine or 15-Valent Pneumococcal Conjugate Vaccine With a Booster Dose of SARS-CoV-2 mRNA Vaccine in Healthy Adults 50 Years of Age or Older.

prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease

booster
conjugate vaccine
chronic illness
polysaccharide
v110
  • 5 views
  • 13 Oct, 2022
  • 44 locations
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) (CARAVAN)

The primary objectives of this study are to evaluate the safety, tolerability, and pharmacokinetics (PK) of remdesivir (RDV) in participants with laboratory-confirmed coronavirus disease 2019

covid-19
coronavirus infection
SARS
remdesivir
  • 380 views
  • 07 Oct, 2022
  • 27 locations
A Study of Hydroxychloroquine Vitamin C Vitamin D and Zinc for the Prevention of COVID-19 Infection

This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent symptoms of COVID-19

vitamin d
hydroxychloroquine
covid-19
Accepts healthy volunteers
zinc
  • 394 views
  • 27 Oct, 2021
  • 1 location
  • 0 views
  • 01 Jul, 2022
  • 14 locations
A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of JT001 (VV116) for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Participants With Mild to Moderate COVID-19.

The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of JT001 (VV116) for the early Treatment of Coronavirus Disease 2019 (COVID-19) in participants with mild to

  • 6 views
  • 16 Oct, 2022
  • 3 locations
A Phase II Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Monovalent and Multivalent RNA-based Vaccines in Healthy Subjects

participants who have not received prior Coronavirus Disease 2019 (COVID-19) vaccination. In addition, the safety and immunogenicity of BNT162b2 (B.1.1.529) or BNT162b2 given as a third or fourth vaccine dose

Accepts healthy volunteers
  • 78 views
  • 17 Oct, 2022
  • 1 location
The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults

SCTV01C-02-1 is a randomized, double-blind, placebo controlled Phase Ⅰ/Ⅱ clinical trial of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant bivalent trimeric S

Accepts healthy volunteers
  • 0 views
  • 21 Mar, 2022
  • 2 locations
Acute Respiratory Infections Global Outpatient Study (ARGOS)

The purpose of this study is to evaluate the positivity rate of respiratory syncytial virus (RSV), influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in high-risk

  • 0 views
  • 18 Oct, 2022
  • 41 locations